Moreover, we performed a genome-wide expression profile analysis to further study heterogeneity in molecular mechanisms through which LYAR participates in the progression of colorectal cancer, demonstrating that LYAR plays a role in the promotion of CRC invasion and metastasis by upregulating FSCN1 expression. Here, FSCN1 is linked to colorectal carcinoma.